Development of Effective New Treatments for Multiple Myeloma
Author:
Affiliation:
1. From the Division of Hematologic Neoplasia, Dana-Farber Cancer Institute, Boston, MA; and Office of Oncology Drug Products and Division of Oncology Drug Products, US Food and Drug Administration, Rockville, MD
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.02.4950
Reference11 articles.
1. Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
2. CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH-DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
3. Lightcap ES, McCormack TA, Pien CS, et al: Proteasome inhibition measurements: Clinical application. Clin Chem 46:673,2000-683,
4. Aghajanian C, Soignet S, Dizon DS, et al: A phase 1 trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. Clin Cancer Res 8:2505,2002-2511,
5. Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways;Clinical Lymphoma Myeloma and Leukemia;2018-05
2. A Practical Guide to Designing Phase II Trials in Oncology;STAT PRACT;2014-04-25
3. References;A Practical Guide to Designing Phase II Trials in Oncology;2014-04-11
4. Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity;Experimental Hematology;2013-02
5. Bench-to-bedside translation of targeted therapies in multiple myeloma;Community Oncology;2012-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3